Pathological SM is associated with a significantly higher risk of first-trimester abortion. Therefore, SM is highlighted as a potential predictor of IUI outcomes following clinical pregnancy. Subsequently, SM should be considered a critical factor in fertility assessments, and alternative treatment strategies may be more appropriate for couples with pathological SM undergoing infertility treatment.
Nikbakht et al. (Mon,) studied this question.